Claude Labrie
Université du Québec à Montréal · 162 works · 10,683 citations · h-index 51
Top works
- Structure of Two in Tandem Human 17β-Hydroxysteroid Dehydrogenase Genes
- Characterization of cDNAs for Human Estradiol 17β-Dehydrogenase and Assignment of the Gene to Chromosome 17: Evidence of two mRNA Species with Distinct 5′-Termini in Human Placenta
- Full Length cDNA Structure and Deduced Amino Acid Sequence of Human β-Hydroxy-5-Ene Steroid Dehydrogenase
- The key role of 17β-hydroxysteroid dehydrogenases in sex steroid biology
- Endocrine and Intracrine Sources of Androgens in Women: Inhibition of Breast Cancer and Other Roles of Androgens and Their Precursor Dehydroepiandrosterone
- Expression and neuropeptidergic characterization of estrogen receptors (ER? and ER?) throughout the rat brain: Anatomical evidence of distinct roles of each subtype
- DHEA and the Intracrine Formation of Androgens and Estrogens in Peripheral Target Tissues: Its Role during Aging
- DHEA and Peripheral Androgen and Estrogen Formation: Intracrinology
- Characterization of rat 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase cDNAs and differential tissue-specific expression of the corresponding mRNAs in steroidogenic and peripheral tissues.
- Characterization of human 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase gene and its expression in mammalian cells
- Is dehydroepiandrosterone a hormone?
- Science behind total androgen blockade: from gene to combination therapy.
- Localization of oestrogen receptor alpha, oestrogen receptor beta and androgen receptors in the rat reproductive organs
- Androgenic Activity of Dehydroepiandrosterone and Androstenedione in the Rat Ventral Prostate
- Intracrinology: role of the family of 17 beta-hydroxysteroid dehydrogenases in human physiology and disease
- DHEA and Its Transformation into Androgens and Estrogens in Peripheral Target Tissues: Intracrinology
- Analysis of the androgenic activity of synthetic “progestins” currently used for the treatment of prostate cancer
- Combination therapy for prostate cancer. Endocrine and biologic basis of its choice as new standard first-line therapy
- Molecular cloning, cDNA structure and predicted amino acid sequence of bovine 3β‐hydroxy‐5‐ene steroid dehydrogenase/Δ5‐Δ4 isomerase
- (S)-(+)-4-[7-(2,2-Dimethyl-1-oxopro- poxy)-4-methyl-2-[4-[2-(1-piperidinyl)- ethoxy]phenyl]-2H-1-benzopyran-3-yl]- phenyl 2,2-Dimethylpropanoate (EM-800): A Highly Potent, Specific, and Orally Active Nonsteroidal Antiestrogen